Bullous pemphigoid in patients receiving peritoneal dialysis: a case series and a literature survey

References

• Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–332.
   PubMed Web of Science ®Google Scholar
• Cozzani E, Gasparini G, Burlando M, et al. Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects. Autoimmun Rev. 2015;14(5):438–445.
   PubMed Web of Science ®Google Scholar
• Hammers CM, Stanley JR. Recent advances in understanding pemphigus and bullous pemphigoid. J Invest Dermatol. 2020;140(4):733–741.
   PubMed Web of Science ®Google Scholar
• Sato M, Terui T, Tabata N, et al. Bullous pemphigoid masquerading as porphyria cutanea tarda in a patient on haemodialysis. Br J Dermatol. 1993;129(5):642–643.
   PubMed Web of Science ®Google Scholar
• Freeman BD, Rubin BG. Bullous pemphigoid after prosthetic vascular graft placement. Surgery. 1998;124(1):112–113.
   PubMed Web of Science ®Google Scholar
• Kamada N, Ino N, Hatamochi A, et al. A case of bullous pemphigoid in a patient on hemodialysis. J Dermatol. 1998;25(4):246–249.
   PubMedGoogle Scholar
• Yesudian PD, Dobson CM, Ahmad R, et al. Trauma-induced bullous pemphigoid around venous access site in a haemodialysis patient. Clin Exp Dermatol. 2002;27(1):70–72.
   PubMed Web of Science ®Google Scholar
• Pardo J, Rodrguez-Serna M, Mercader P, et al. Localized bullous pemphigoid overlying a fistula for hemodialysis. J Am Acad Dermatol. 2004;51(2 Suppl):S131–S132.
   PubMed Web of Science ®Google Scholar
• Seneschal J, Héliot-Hostein I, Taieb A. Pancytopenia induced by low-dose methotrexate in a haemodialysis patient treated for bullous pemphigoid. J Eur Acad Dermatol Venereol. 2007;21(8):1135–1136.
   PubMed Web of Science ®Google Scholar
• Peruzzo J, Dias Pinheiro Dantas L, Zampese M. Bullous pemphigoid associated with chronic renal allograft rejection. J Am Acad Dermatol. 2013;68(6):e192–e193.
   PubMed Web of Science ®Google Scholar
• Sodemoto K, Yamahana J, Echigo T, et al. Development of bullous pemphigoid after change of dialysis membrane. Hemodial Int. 2014;18(2):525–528.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu F, Zhang M, et al. Combined acute interstitial pneumonitis and pancytopenia induced by low-dose methotrexate in a hemodialysis patient treated for bullous pemphigoid. An Bras Dermatol. 2015;90(3 Suppl 1):S43–S45.
   PubMed Web of Science ®Google Scholar
• Osipowicz K, Kalinska-Bienias A, Kowalewski C, et al. Development of bullous pemphigoid during the haemodialysis of a young man: case report and literature survey. Int Wound J. 2017;14(1):288–292.
   PubMed Web of Science ®Google Scholar
• Abdul Salim S, Thomas L, Quorles A, et al. New diagnosis of bullous pemphigoid after withdrawal of immunosuppressive therapy in a failed renal transplant recipient on hemodialysis. Hemodial Int. 2018;22(2):E26–E32.
   PubMed Web of Science ®Google Scholar
• Takeichi S, Kubo Y, Arase S, et al. Brunsting–Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure. Eur J Dermatol. 2009;19(5):500–503.
   PubMedGoogle Scholar
• Giunzioni D. Development of bullous pemphigoid after Tenckhoff catheter placement in a peritoneal dialysis patient. Case Rep Dermatol. 2020;12(1):42–46.
   PubMed Web of Science ®Google Scholar
• Stanley JR, Hawley-Nelson P, Yuspa SH, et al. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981;24(3):897–903.
   PubMed Web of Science ®Google Scholar
• Diaz LA, Ratrie H, Saunders WS, et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990;86(4):1088–1094.
   PubMed Web of Science ®Google Scholar
• Brodin P, Davis MM. Human immune system variation. Nat Rev Immunol. 2017;17(1):21–29.
   PubMed Web of Science ®Google Scholar
• Vadasz Z, Haj T, Kessel A, et al. Age-related autoimmunity. BMC Med. 2013;11:94.
   PubMed Web of Science ®Google Scholar
• Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28(9):1133–1140.
   PubMed Web of Science ®Google Scholar
• Schulze F, Neumann K, Recke A, et al. Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol. 2015;135(5):1445–1447.
   PubMed Web of Science ®Google Scholar
• Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J Invest Dermatol. 2011;131(3):631–636.
   PubMed Web of Science ®Google Scholar
• Dănescu S, Chiorean R, Macovei V, et al. Role of physical factors in the pathogenesis of bullous pemphigoid: case report series and a comprehensive review of the published work. J Dermatol. 2016;43(2):134–140.
   PubMed Web of Science ®Google Scholar
• Cabrera VJ, Hansson J, Kliger AS, et al. Symptom management of the patient with CKD: the role of dialysis. Clin J Am Soc Nephrol. 2017;12(4):687–693.
   PubMed Web of Science ®Google Scholar
• Solak B, Acikgoz SB, Sipahi S, et al. Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients. Int Urol Nephrol. 2016;48(4):585–591.
   PubMed Web of Science ®Google Scholar
• Mathur VS, Lindberg J, Germain M, ITCH National Registry Investigators, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410–1419.
   PubMed Web of Science ®Google Scholar
• Sesarman A, Oswald E, Chiriac MT, et al. Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice? Immunol Lett. 2012;143(1):92–100.
   PubMed Web of Science ®Google Scholar
• Cevher ŞK, Ozkayar N, Dede F. A case report on allergic rash caused by icodextrin. Case Rep Nephrol Dial. 2015;5(1):26–29.
   PubMed Web of Science ®Google Scholar
• Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J Allergy Clin Immunol. 2020;145(4):1031–1047.
   PubMed Web of Science ®Google Scholar
• Fathi F, Atapour A, Eskandari N, et al. Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus. Int J Immunopathol Pharmacol. 2019;33:205873841986323–2058738419863238.
   Web of Science ®Google Scholar
• Liappas G, Gónzalez-Mateo GT, Majano P, et al. T helper 17/regulatory T cell balance and experimental models of peritoneal dialysis-induced damage. Biomed Res Int. 2015;2015:1–9.
   Web of Science ®Google Scholar